The most scientifically advanced bioinformatics available

Aperiomics Xplore-MicroBiome can characterize any known microorganism in any sample. We are experts at analyzing extensive datasets that lead to meaningful results.

Your Sequencing and Bioinformatics Partner

Aperiomics partners with organizations and researcher institutions on clinical trials, genetic monitoring, biosurveillance, pathogen identification, microbiome characterization, quality monitoring programs, and more.

Set Up a Research Consultation

Take Advantage of Our Services

As part of your team, we can assist in study design and deliver customized data/reporting and journal-ready graphics. We also offer discounts for research authorship collaboration.

Collection Kits

Extraction and Library Preparation

Metagenomic SequencingData Analysis

Microbe Identification

Frequently Used Applications


Fecal Microbiota Transplant (FMT) Before/After Analysis

Targeted Therapeutic Outcome Validation

Microbiome Characterization

Clinical Trial Research

Pathogen Detection


Environmental Microbiome Analysis

Water Monitoring



Crop Pathogen Detection and Microbiome Analysis

Animal Health and Wellness

Soil and Environmental Analysis

Veterinary Testing

Food Safety

Don’t Sacrifice Data By Using Older Methods

A common form of next-generation sequencing, 16s, examines only ~0.001% of the DNA in a sample. Our deep metagenomic sequencing allows Xplore-MicroBiome to examine up to 100% of the DNA in a sample, providing 100,000 times more information.

PCR and 16s
Identifies the Following:
GenomeUp to 100%~0.001%
Microbes identified to species level>37,000-
Differentiates Species
Cost per microbe$0.03-0.05Up to $300

Aperiomics: The Way Forward

Cutting-edge technology powered by proven scientific advances

Clinically actionable data for healthcare providers

Extensive datasets that provide answers no others can give

Proven Technology

“Next generation sequencing metagenomics allows much deeper characterization of the microbiome complexity, allowing identification of a larger number of species for each sample, compared to 16s rDNA amplicon sequencing.”


Laudadio, et al., 2018